Leukotriene quantitation
In all participants, the lower ratio of n-3 to n-6 PUFAs, ie, 0.1:1, was associated with an increase (13.2 ± 4.5 ng, P < 0.05) in total 4-series leukotriene excretion and a nonsignificant increase (7.8 ± 1.4 ng) in LTE5 excretion. At low n-3 PUFA ingestion, there was no significant difference in 4-series, S-series, or overall leukotriene excretion between responders and nonresponders ( Figure  2 ). Ratioofn -3 to n -6PUFAs of0.l:l (n Ratio of n -3 to n -6 PUFAs of 0.5:1
Nonresponders (n -10)
19)
24.1 ± 1.7 11.8 ± 3.1 NC2 3.7 ± 1.4 cumulative methacholine units 16.9 ± 1.9 17.1 ± 2.7
1.9± 1.7 5.9 ± 2.1 NC NC 4.9 ± 2.4 3.5 ± 3.9
9.0 ± 1.2 0.7 ± 2.0 NC 9.9 ± 1.2 ' I ± SEM. PlC, forced vital capacity: 
